Your browser doesn't support javascript.
loading
Crystal structures of the SARS-CoV-2 nucleocapsid protein C-terminal domain and development of nucleocapsid-targeting nanobodies.
Jia, Zhenghu; Liu, Chen; Chen, Yuewen; Jiang, Heng; Wang, Zijing; Yao, Jialu; Yang, Jie; Zhu, Jiaxing; Zhang, Boqing; Yuchi, Zhiguang.
Affiliation
  • Jia Z; The First Affiliated Hospital, Biomedical Translational Research Institute and Guangdong Province Key Laboratory of Molecular Immunology and Antibody Engineering, Jinan University, Guangzhou, China.
  • Liu C; Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, China.
  • Chen Y; International Research Center for precision medicine, Beroni Group Limited, Sydney, Australia.
  • Jiang H; Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, China.
  • Wang Z; Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, China.
  • Yao J; Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, China.
  • Yang J; Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, China.
  • Zhu J; Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, China.
  • Zhang B; International Research Center for precision medicine, Beroni Group Limited, Sydney, Australia.
  • Yuchi Z; International Research Center for precision medicine, Beroni Group Limited, Sydney, Australia.
FEBS J ; 289(13): 3813-3825, 2022 07.
Article in En | MEDLINE | ID: mdl-34665939
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Single-Domain Antibodies / Coronavirus Nucleocapsid Proteins Language: En Journal: FEBS J Journal subject: BIOQUIMICA Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Single-Domain Antibodies / Coronavirus Nucleocapsid Proteins Language: En Journal: FEBS J Journal subject: BIOQUIMICA Year: 2022 Document type: Article Affiliation country: Country of publication: